Hematologic malignancies, hematopoietic cell transplantation, cellular therapies, physical function measurement and intervention, physiologic sensors, digital biomarker development, health coaching, digital medicine implementation, quality measurement and improvement in cancer care
BA: Harvard University, 1994; MD: Duke University, 2003; MPH: University of North Carolina, 2003; Fellowship: University of North Carolina, 2007-2010; Assistant Professor of Medicine: University of North Carolina, 2010-2016; Associate Professor of Medicine, 2016-present.
I am a hematologist and oncologist with a clinical focus in blood cancers, hematopoietic cell transplantation and cellular therapy. Research interests include novel strategies to measure and intervene upon physical function during and after cancer treatment. Digital biomarker development, physiologic sensor integration, home-based functional assessments, patient reported outcomes implementation, and health coaching are areas of current efforts. A major goal is to leverage emerging technologies to improve the cancer patient experience. I am involved in a number of local, state-wide, national and international digital medicine collaborations and research initiatives. I am also the current chair of the American Society of Hematology Research Collaborative’s Data Hub Oversight Group. The ASH Research Collaborative Data Hub aims to become one of the world’s largest repositories of research grade clinical data in selected benign and malignant hematologic diseases, starting with sickle cell disease and multiple myeloma, with expansion expected to other diseases over the next several years.